Survey on the Pharmacy Follow-up of Alli Purchasers

• Status: Completed
• Trial end date: 2010-12-01
• Target enrollment: 0
• Participant gender: All

Summary

To assess the feasibility and acceptability of genuine pharmacy follow up of people wishing to lose weight.

• Accepts Healthy Volunteers?: No

Details

• Lead Sponsor: GlaxoSmithKline
• Treatments: Orlistat

Criteria

Inclusion Criteria:

• Individuals who have been recognized as being eligible for treatment, who have agreed to pharmacy follow up, and have given their informed consent to take part in the survey.